• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 31 Jul 2025

Solid 2Q:25 Results Pale Against Uncertain Near Term Order Timing; Opportunity Pipeline Grows, Even As Volume Ramp Is Pushed Out; Operational Performance Improved; Maintain $10 Target


Orion Group (ORN:NYSE) | 0 0 0.0%


  • Sidoti & Company
    • Julio Romero

    • 11 pages


 

Orion reported 2Q:25 results that bested our expectations, led by a third consecutive quarter of Marine segment margin outperformance on disciplined and efficient project closeouts. Backlog decreased sequentially by 11% to $746 million (book-to-bill 0.5x), as private sector customers involved in public-private projects delayed decision making on projects amid macroeconomic and tariff uncertainties. Guidance was reaffirmed for 2025, with revenue of $800-$850 million, and adjusted EBITDA of $42-$46 million. We think the uncertainty with regards to the timing of order intake led to yesterday's 15% pullback in shares (versus the less than 1% decline of the Russell 2000). We lower our 2026 estimates to better reflect lumpiness in award timing that likely pushes the expected volume ramp to unfold over 2026-2027 rather than just 2026. Still, we view Orion's growing sales opportunity set as largely intact, as evidenced by the increased opportunity pipeline ($18 billion, up from $16 billion in 1Q:25) and positive demand commentary. Post quarter-end, ORN paid down $10 million of revolver debt. Our moderate risk rating reflects ORN's improved financial profile. We maintain a $10 price target, based on 22x our newly introduced 2027 EPS estimate of $0.47. (Previously we valued ORN shares at 22x our prior 2026 EPS estimate of $0.46 to derive the same $10 price target).

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

Solid 2Q:25 Results Pale Against Uncertain Near Term Order Timing; Opportunity Pipeline Grows, Even As Volume Ramp Is Pushed Out; Operational Performance Improved; Maintain $10 Target


Orion Group (ORN:NYSE) | 0 0 0.0%


  • Published: 31 Jul 2025
  • Author: Julio Romero
  • Pages: 11
  • Sidoti & Company


Orion reported 2Q:25 results that bested our expectations, led by a third consecutive quarter of Marine segment margin outperformance on disciplined and efficient project closeouts. Backlog decreased sequentially by 11% to $746 million (book-to-bill 0.5x), as private sector customers involved in public-private projects delayed decision making on projects amid macroeconomic and tariff uncertainties. Guidance was reaffirmed for 2025, with revenue of $800-$850 million, and adjusted EBITDA of $42-$46 million. We think the uncertainty with regards to the timing of order intake led to yesterday's 15% pullback in shares (versus the less than 1% decline of the Russell 2000). We lower our 2026 estimates to better reflect lumpiness in award timing that likely pushes the expected volume ramp to unfold over 2026-2027 rather than just 2026. Still, we view Orion's growing sales opportunity set as largely intact, as evidenced by the increased opportunity pipeline ($18 billion, up from $16 billion in 1Q:25) and positive demand commentary. Post quarter-end, ORN paid down $10 million of revolver debt. Our moderate risk rating reflects ORN's improved financial profile. We maintain a $10 price target, based on 22x our newly introduced 2027 EPS estimate of $0.47. (Previously we valued ORN shares at 22x our prior 2026 EPS estimate of $0.46 to derive the same $10 price target).

More Content

More Content

Orion Continues To Position The Company For Scale, In Anticipation Of Increasing Sales Opportunities In 2026 And Beyond; Maintain $10 Price Target

Companies: Orion Group Holdings, Inc. (ORN:NYS)Orion Group (ORN:NYSE)

Sidoti & Company

PANMURE LIBERUM: Severfield: Primed for growth

Companies: Severfield Plc

Panmure Liberum

Severfield:Upside risks to margins and profits

Companies: Severfield Plc

Edison

Cryptocurrencies 28 July 2025

Companies: BTSC BTGN BTCT ADE BTCW COINXBT QBTC BTGN BTM IOTC CASL NMOC NMRD NNE NEM NEM NMX NEMYSIS NEM NEMAKA NMRD ALNEV NLTX NEOD NEO NBCO NEOL NEOG NEN NMT NEO NEOH 1868 NEOE3 NPTN NEO NVC NEM NBM NEO NEOV NEON NMGC NEOLA NEO NGL NEOM BNDI NEOS MLNLF NELR ALNEV ALNLF NCI SPYI 6922 NEO NSP NTX TLTI IAUI NEOGEN NEOL NGI NEO NDT 950220 3921 042420 085910 092730 094860 095660 212560 253590 290660 306620 311390 NEON NTMC NEOFI NPFL NLC NGRD3 NEOG 172A NEOBO BTCI NMGC IWMI 4196 IYRI NTHI HYBI ZVNS 4131 QQQH NBCO NEOM NTGN NEOB CSHI QQQI SPYH SRZ KLH SPX STEL STEL STCS SVCCU PNG ETOR PLUS

Acquisdata

Agilyx - Further GreenDot Development

Companies: Agilyx ASA

Longspur Clean Energy
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
  • LLM Feed
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In